Dr. Antoni Esteve Foundation Research Award 2021
Start date
19/10/2021
Ending date
Location
C. de Melchor Fernández Almagro, 3
0,00€
In 2019, a group from the Centro Nacional de Investigaciones Cardiovasculares published in the journal Nature relevant data around the involvement of the p38gamma protein in the development of the main type of primary liver cancer. This is hepatocellular carcinoma, which affects more than one million people a year worldwide and for which few pharmacological options are currently available.
The international tribunal that awards the Dr. Antoni Esteve Foundation Research Award has considered this scientific article as the most important pharmacological publication published by a Spanish author between 2019 and 2020.
The article p38γ is essential for cell cycle progression and liver tumorigenesis not only discovers how the p38gamma protein is related to cell division in the liver but has also studied in mice what happened when they were chemically induced by liver cancer with or without this protein.
The CNIC team has been studying a family of proteins, p38 kinases, for several years, which are activated when cells experience any type of stress.
The members of the international jury of the Dr. Antoni Esteve also wanted to recognize with an honorable mention the article published in 2019 in the journal Nature Metabolism by the group of the Instituto de Investigación Sanitaria de Santiago and the University of Santiago de Compostela in which they discover the mechanism by which some drugs used for the treatment of other diseases also decrease body weight.
This is the seventeenth edition of the Dr. Foundation Research Award. Antoni Esteve, which is awarded to the best work in pharmacology published by a Spanish author in the last two years in any of its aspects (design, synthesis, galenic development, clinical or laboratory evaluation, use, etc.).
Online reservations are not available for this event.